ArticleFrontiers in immunology2026

Case Report: Primary gallbladder undifferentiated small round cell sarcomas treated with gemcitabine, paclitaxel, bevacizumab and pembrolizumab achieved remarkable tumor regression.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.